Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS
· Delayed Price · Currency is USD
0.5400
0.00 (0.00%)
May 21, 2025, 4:00 PM EDT
Mosaic ImmunoEngineering Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 0.09 | 0.12 | 0.16 | 0.22 | 0.23 | 0.35 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 0.03 | Upgrade
|
| Cash & Short-Term Investments | 0.09 | 0.12 | 0.16 | 0.22 | 0.23 | 0.38 | Upgrade
|
| Cash Growth | 32.12% | -26.35% | -29.22% | -2.43% | -40.55% | 75975.00% | Upgrade
|
| Other Receivables | - | - | - | - | - | 0.03 | Upgrade
|
| Receivables | - | - | - | - | - | 0.03 | Upgrade
|
| Prepaid Expenses | 0.01 | 0.03 | 0.02 | 0.04 | 0.04 | 0.05 | Upgrade
|
| Total Current Assets | 0.1 | 0.14 | 0.18 | 0.26 | 0.27 | 0.46 | Upgrade
|
| Total Assets | 0.1 | 0.14 | 0.18 | 0.26 | 0.27 | 0.46 | Upgrade
|
| Accounts Payable | 0.14 | 0.13 | 0.12 | 0.13 | 0.11 | 0.09 | Upgrade
|
| Accrued Expenses | 5.32 | 5.03 | 4.44 | 3.56 | 1.94 | 0.48 | Upgrade
|
| Short-Term Debt | 0.2 | 0.2 | - | - | - | - | Upgrade
|
| Other Current Liabilities | - | 0.18 | 0.18 | 0.22 | 0.28 | 0.31 | Upgrade
|
| Total Current Liabilities | 5.66 | 5.54 | 4.73 | 3.92 | 2.33 | 0.88 | Upgrade
|
| Long-Term Debt | 1.41 | 1.39 | 1.32 | 1.23 | 0.74 | - | Upgrade
|
| Total Liabilities | 7.07 | 6.93 | 6.05 | 5.15 | 3.07 | 0.88 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 2.05 | 2.05 | 2.05 | 2.02 | 1.73 | 0.42 | Upgrade
|
| Retained Earnings | -9.02 | -8.84 | -7.92 | -6.91 | -4.53 | -0.84 | Upgrade
|
| Comprehensive Income & Other | 0 | - | - | - | - | - | Upgrade
|
| Total Common Equity | -6.97 | -6.79 | -5.87 | -4.88 | -2.8 | -0.42 | Upgrade
|
| Shareholders' Equity | -6.97 | -6.79 | -5.87 | -4.88 | -2.8 | -0.42 | Upgrade
|
| Total Liabilities & Equity | 0.1 | 0.14 | 0.18 | 0.26 | 0.27 | 0.46 | Upgrade
|
| Total Debt | 1.61 | 1.59 | 1.32 | 1.23 | 0.74 | - | Upgrade
|
| Net Cash (Debt) | -1.52 | -1.48 | -1.16 | -1.01 | -0.51 | 0.38 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | 75975.00% | Upgrade
|
| Net Cash Per Share | -0.21 | -0.20 | -0.16 | -0.14 | -0.08 | 0.51 | Upgrade
|
| Filing Date Shares Outstanding | 7.24 | 7.24 | 7.24 | 7.24 | 7.24 | 7.23 | Upgrade
|
| Total Common Shares Outstanding | 7.24 | 7.24 | 7.24 | 7.24 | 7.24 | 0.81 | Upgrade
|
| Working Capital | -5.56 | -5.4 | -4.55 | -3.66 | -2.06 | -0.42 | Upgrade
|
| Book Value Per Share | -0.96 | -0.94 | -0.81 | -0.67 | -0.39 | -0.52 | Upgrade
|
| Tangible Book Value | -6.97 | -6.79 | -5.87 | -4.88 | -2.8 | -0.42 | Upgrade
|
| Tangible Book Value Per Share | -0.96 | -0.94 | -0.81 | -0.67 | -0.39 | -0.52 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.